Core Laboratories Inc. /DE/CLB決算レポート
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.
CLB Q4 2025 Key Financial Metrics
売上高
$138.3M
粗利益
$28.7M
営業利益
$15.8M
純利益
$4.9M
粗利益率
20.8%
営業利益率
11.5%
純利益率
3.6%
前年比成長
7.0%
EPS
$0.11
資金フロー
Core Laboratories Inc. /DE/ Q4 2025 財務サマリー
Core Laboratories Inc. /DE/ reported revenue of $138.3M (up 7.0% YoY) for Q4 2025, with a net profit of $4.9M (down 33.2% YoY) (3.6% margin). Cost of goods sold was $109.5M, operating expenses totaled $12.9M.
主要財務指標
| 総売上高 | $138.3M |
|---|---|
| 純利益 | $4.9M |
| 粗利益率 | 20.8% |
| 営業利益率 | 11.5% |
| 報告期間 | Q4 2025 |
売上内訳
Core Laboratories Inc. /DE/ Q4 2025 revenue of $138.3M breaks down across 2 segments, led by Services at $107.0M (77.4% of total).
| セグメント | 売上高 | 構成比 |
|---|---|---|
| Services | $107.0M | 77.4% |
| Products | $31.3M | 22.6% |
Core Laboratories Inc. /DE/ セグメント別売上 — 四半期推移
Core Laboratories Inc. /DE/ revenue by segment across the last 4 reported quarters, showing how each business line (such as Services and Products) has evolved quarter over quarter.
| セグメント | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Services | $107.0M | $101.1M | $96.2M | $95.1M |
| Products | $31.3M | $33.4M | $33.9M | $28.5M |
Core Laboratories Inc. /DE/ 年度売上推移
Core Laboratories Inc. /DE/ annual revenue history includes year-by-year totals (for example, 2025 revenue was $526.5M). Click any linked year to see what changed vs the prior 10-K.
Core Laboratories Inc. /DE/ 四半期売上・純利益の履歴
Core Laboratories Inc. /DE/ quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 四半期 | 売上高 | 売上前年比 | 純利益 | 純利益率 |
|---|---|---|---|---|
| Q4 2025 | $138.3M | +7.0% | $4.9M | 3.6% |
| Q3 2025 | $134.5M | +0.1% | $14.2M | 10.6% |
| Q2 2025 | $130.2M | -0.3% | $10.6M | 8.2% |
| Q1 2025 | $123.6M | -4.7% | $-154.0K | -0.1% |
| Q4 2024 | $129.2M | — | $7.4M | 5.7% |
| Q3 2024 | $134.4M | +7.2% | $11.7M | 8.7% |
| Q2 2024 | $130.6M | +2.1% | $9.0M | 6.9% |
| Q1 2024 | $129.6M | — | $3.2M | 2.5% |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $129.6M | $130.6M | $134.4M | $129.2M | $123.6M | $130.2M | $134.5M | $138.3M |
| 前年比成長 | N/A | 2.1% | 7.2% | N/A | -4.7% | -0.3% | 0.1% | 7.0% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $597.8M | $597.8M | $600.5M | $585.1M | $591.5M | $602.1M | $591.4M | $584.0M |
| 総負債 | $365.6M | $357.5M | $349.7M | $338.6M | $338.1M | $340.8M | $320.0M | $318.0M |
| 株主資本 | $232.2M | $240.3M | $250.7M | $246.6M | $253.4M | $261.3M | $271.3M | $266.0M |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $5.5M | $17.1M | $13.1M | $20.6M | $6.7M | $13.9M | $8.5M | $7.9M |